A House panel passed a bill to ban drug middlemen from tying fees to list prices...
At first, Eli Lilly's earnings report suggested the company had blasted through ...
Five years after HCA Healthcare took over an esteemed nonprofit hospital in Nort...
The Colombian government has taken a significant step toward issuing a compulsor...
A doctor who treats people with Alzheimer’s doesn't blame Biogen for the Aduhelm...
The Supreme Court is set to hear arguments next month in a case that could have ...
Why @adamfeuerstein believes Novartis is going to walk away from its acquisition...
Vertex’s once-daily cystic fibrosis therapy succeeded in a pair of Phase 3 studi...
Johnson & Johnson faces a consequential new class action lawsuit for allegedly o...
Fatigue is common among long Covid patients, which means that recommendations to...
The case study, about how Krystal Biotech's gene therapy for a rare genetic cond...
The government boiled down its rules about Medicare Advantage plans using AI to ...
Working with the cells of people with peanut allergies, researchers identify a "...
Health Canada has approved Chiesi Global Rare Diseases’ MYALEPTA as a treatment ...
Silence Therapeutics has announced a private placement of its 5,714,286 American...
Incyte has acquired sole worldwide rights to tafasitamab immunotherapy through a...
